Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia

被引:57
作者
Peel, T. [1 ]
Cheng, A. C. [2 ,3 ]
Spelman, T. [4 ]
Huysmans, M. [5 ]
Spelman, D. [2 ]
机构
[1] St Vincents Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[2] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[3] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[4] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[5] Alfred Hosp, Dept Microbiol, Melbourne, Vic, Australia
关键词
Enterococcal bacteraemia; epidemiological methods; risk factors; vancomycin resistance; BLOOD-STREAM INFECTIONS; ANTIMICROBIAL RESISTANCE; HOSPITALIZED-PATIENTS; MORTALITY; MEROPENEM; FAECIUM; EPIDEMIOLOGY; MULTICENTER; PREDICTORS; FAECALIS;
D O I
10.1111/j.1469-0691.2011.03591.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Enterococcus is an important cause of bacteraemia. Previous epidemiological studies examining risk factors for enterococcal bacteraemia have used traditional case-control study designs, which can be potentially biased. This case-case-control study examining risk factors for enterococcal bacteraemia was conducted over 10 years (January 2000 to December 2009) in a tertiary, university-affiliated hospital. There were 440 episodes of enterococcal bacteraemia, 80 of which were caused by vancomycin-resistant Enterococcus (VRE). Two multivariable models were generated, comparing VRE and vancomycin-susceptible Enterococcus (VSE) with the same control group. VRE bacteraemia was associated with central venous catheter use (OR 11.6, 95% CI 2.6-51.5), neutropenia (OR 16.9, 95% CI 2.4-120.2), and allogenic bone marrow transplantation (OR 18.0, 95% CI 2.4-133.4). In contrast, VSE bacteraemia risk factors included: age (OR 1.0, 95% CI 1.0-1.1), exposure to metronidazole (OR 8.7, 95% CI 1.7-43.5), and gastrointestinal disease (OR 6.4, 95% CI 1.2-34.5). Meropenem use decreased the risk of VSE bacteraemia (OR 0.3, 95% CI 0.1-0.9). Hypoalbuminaemia was the only factor identified in both models (VRE, OR 6.0, 95% CI 1.7-21.1; VSE, OR 3.3, 95% CI 1.4-7.7). The absence of substantial overlap of risk factors for VRE and VSE argues in favour of differences in pathogenesis. These data suggest that environmental sources are more important in VRE bacteraemia. Endogenous sources, particularly the gastrointestinal tract, play a pivotal role in VSE bacteraemia. This study highlights the importance of infection control protocols to reduce the risk of VRE bacteraemia.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 24 条
  • [1] Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course
    Avery, R
    Kalaycio, M
    Pohlman, B
    Sobecks, R
    Kuczkowski, E
    Andresen, S
    Mossad, S
    Shamp, J
    Curtis, J
    Kosar, J
    Sands, K
    Serafin, M
    Bolwell, B
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 497 - 499
  • [2] Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates
    Bell, JM
    Paton, JC
    Turnidge, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) : 2187 - 2190
  • [3] A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
    Bhavnani, SM
    Drake, JA
    Forrest, A
    Deinhart, JA
    Jones, RN
    Biedenbach, DJ
    Ballow, CH
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (03) : 145 - 158
  • [4] Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients:: An analysis of two case-control studies
    Campos Furtado, Guilherme Henrique
    Mendes, Rodrigo Elisandro
    Campos Pignatari, Antonio Carlos
    Wey, Sergio Barsanti
    Servolo Medeiros, Eduardo Alexandrino
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2006, 34 (07) : 447 - 451
  • [5] Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis
    DiazGranados, CA
    Zimmer, SM
    Klein, M
    Jernigan, JA
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) : 327 - 333
  • [6] A 25-year study of nosocomial bacteremia in an adult intensive care unit
    Edgeworth, JD
    Treacher, DF
    Eykyn, SJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (08) : 1421 - 1428
  • [7] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION
    EDMOND, MB
    OBER, JF
    WEINBAUM, DL
    PFALLER, MA
    HWANG, T
    SANFORD, MD
    WENZEL, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1126 - 1133
  • [8] Comparative in-vitro activity of meropenem against selected pathogens from hospitalized patients in The Netherlands
    Endtz, HP
    vanDijk, WC
    Verbrugh, HA
    Bakker, LJ
    Bernards, AT
    Brimicombe, RW
    Buiting, AGM
    Dankert, J
    DebetsOssenkopp, Y
    Degener, JE
    Diepersloot, RJA
    VanDijke, BJ
    Fabius, GTJ
    HoogkampKorstanje, JAA
    Lim, BT
    Manson, WL
    Nohlmans, MKE
    Overbeek, BP
    Sabbe, LJM
    Schreuder, H
    Sebens, FW
    Severin, WPJ
    Stobberingh, E
    Thewessen, EAPM
    Timmerman, CP
    Yzerman, EPF
    Wagenvoort, JHT
    Wolfhagen, MJHM
    Visser, MR
    Vreede, RW
    vanZeijl, JA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) : 149 - 156
  • [9] Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital
    Greenberg, BM
    Atmar, RL
    Stager, CE
    Greenberg, SB
    [J]. JOURNAL OF INFECTION, 2005, 50 (04) : 288 - 295
  • [10] Control-group selection importance in studies of antimicrobial resistance:: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli
    Harris, AD
    Samore, MH
    Lipsitch, M
    Kaye, KS
    Perencevich, E
    Carmeli, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) : 1558 - 1563